Abstract:The progressive loss and degeneration of neurons in the central nervous system (CNS), as a result of traumas or diseases including Alzheimer’s, Parkinson’s, Huntington’s disease, stroke, and traumatic injury to the brain and spinal cord, can usually have devastating effects on quality of life. The current strategies available for treatments are described including drug delivery, surgery, electrical stimulation, and cell-based tissue engineering approaches. However, apart from cell-based therapy, other attempts are limited in improving clinical outcomes. Recently, stem cell and neural stem cell (NSC) in particular therapy has been proposed as an attractive and promising strategy for regenerative medicine due to their unique biological attributes, such as giving rise to neuronal lineage commitment in accordance with the neural development. Nevertheless, stem cell strategy still faces numerous challenges, including ethical issue, tumor formation, and graft rejection. Thus, seeking a more appropriate approach like direct reprogramming or lineage reprogramming is critical. Compared to induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), direct lineage reprogramming of somatic cells to generate induced neurons (iNs) without undergoing a state of pluripotent still has several advantages such as short induction cycle, high transdifferentiation efficiency, no ethical concerns, and risk of neoplasia. On the basis of these advantages, cell reprogramming will hold great promise for therapeutic cell replacement, disease modeling establishment, drug screening, and personalized medicine. Here, we systematically review recent advances in somatic lineage reprogramming into iNs, including the identification of novel reprogramming factors, the underlying molecular mechanisms and the concerns exist, as well as the major challenges in the future.

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Attenuation of PRRX2 and HEY2 Enables Efficient Conversion of Adult Human Skin Fibroblasts to Neurons.

Generation of Human Neurons by microRNA-Mediated Direct Conversion of Dermal Fibroblasts

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Direct Reprogramming of Fibroblasts into Neural Stem Cells by Single Non-Neural Progenitor Transcription Factor Ptf1a

Human Induced Pluripotent Stem Cell-Derived Pericytes As Scalable and Editable Source to Study Direct Lineage Reprogramming into Induced Neurons.

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules

Reprogramming of Adult Human Neural Stem Cells into Induced Pluripotent Stem Cells

Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons.

Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons

Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State.

Reprogramming Fibroblasts Toward Cardiomyocytes, Neural Stem Cells and Hepatocytes by Cell Activation and Signaling-Directed Lineage Conversion

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Direct Conversion of Somatic Cells into Induced Neurons

Generation of Human Striatal Neurons by MicroRNA-Dependent Direct Conversion of Fibroblasts

Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons.